Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-26 @ 3:17 AM
Study NCT ID:
NCT05038020
Status:
TERMINATED
Last Update Posted:
2023-11-01
First Post:
2021-07-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy of Oral AKST4290 in Participants With Moderately Severe to Severe Diabetic Retinopathy (CAPRI)
Sponsor:
Alkahest, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-17
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-19
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-29
First Submit QC Date:
None
Study First Post Date:
2021-09-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-02-16
Results First Submit QC Date:
None
Results First Post Date:
2023-11-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-09
Last Update Post Date:
2023-11-01
Last Update Post Date Type:
ACTUAL